Weekly Microneedle Patch for Overactive Bladder

About TSRL Inc

TSRL, Inc. is a long-established, science-first preclinical CRO that offers a full suite of early development services including formulation, bioanalysis, PK/ADME, and toxicology. The company differentiates itself by combining these services with strategic consulting and proprietary drug delivery technology development, aiming to de-risk programs and guide clients toward licensing or business formation. With a 7,200 sq. ft. facility and a track record spanning nearly four decades, TSRL serves a broad client base while also advancing its own technology platforms through grant funding, such as a recent $2.2 million NIH SBIR grant for a microneedle patch for overactive bladder.

Other Overactive Bladder (OAB) Drugs